Patent classifications
C07C69/34
CITRATE-BASED PLASTICIZER COMPOSITION AND RESIN COMPOSITION COMPRISING SAME
The present invention relates to a plasticizer composition, including a lower alkyl-based citrate and a higher alkyl-based citrate at the same time, as citrate, wherein the ratio of a hybrid type to a non-hybrid type and the ratio of the lower alkyl groups to the higher alkyl groups are controlled so that effects are achieved. When applying the plasticizer composition to a resin, stress resistance and mechanical properties can be maintained at an equal or higher level, the migration and volatile loss properties and the plasticization efficiency can be balanced, and the light resistance and heat resistance can be remarkably improved.
CITRATE-BASED PLASTICIZER COMPOSITION AND RESIN COMPOSITION COMPRISING SAME
The present invention relates to a plasticizer composition, including a lower alkyl-based citrate and a higher alkyl-based citrate at the same time, as citrate, wherein the ratio of a hybrid type to a non-hybrid type and the ratio of the lower alkyl groups to the higher alkyl groups are controlled so that effects are achieved. When applying the plasticizer composition to a resin, stress resistance and mechanical properties can be maintained at an equal or higher level, the migration and volatile loss properties and the plasticization efficiency can be balanced, and the light resistance and heat resistance can be remarkably improved.
Process for preparing azelaic acid
A process for preparing azelaic acid is disclosed. In particular, the process for preparing azelaic acid is an ozone free process. The process for preparing azelaic acid comprises a step of decarboxylation of tetra-carboxylic acid in the presence of a organic sulfonic acid.
Process for preparing azelaic acid
A process for preparing azelaic acid is disclosed. In particular, the process for preparing azelaic acid is an ozone free process. The process for preparing azelaic acid comprises a step of decarboxylation of tetra-carboxylic acid in the presence of a organic sulfonic acid.
ELECTROCHEMICAL PROCESS FOR PRODUCTION OF TETRAALKYL 1,2,3,4-BUTANETETRACARBOXYLATES
An electrochemical process produces tetraalkyl 1,2,3,4-butanetetracarboxylates having alkyl groups with 1 to 6 carbon atoms. The process employs an electrohydrodimerization of dialkyl maleates having alkyl groups having 1 to 6 carbon atoms in a reactant solution with an alcohol and a conducting salt.
ELECTROCHEMICAL PROCESS FOR PRODUCTION OF TETRAALKYL 1,2,3,4-BUTANETETRACARBOXYLATES
An electrochemical process produces tetraalkyl 1,2,3,4-butanetetracarboxylates having alkyl groups with 1 to 6 carbon atoms. The process employs an electrohydrodimerization of dialkyl maleates having alkyl groups having 1 to 6 carbon atoms in a reactant solution with an alcohol and a conducting salt.
TWO-STAGE PROCESS FOR PRODUCING TETRAALKYL 1,2,3,4 BUTANETETRACARBOXYLATES
A two-stage process produces tetraalkyl 1,2,3,4-butanetetracarboxylates having alkyl groups with 1 to 6 carbon atoms starting from tetrahydrophthalic anhydride (THPA). The process starts with an oxidation of tetrahydrophthalic anhydride (THPA), followed by a subsequent esterification of the resulting 1,2,3,4-butanetetracarboxylic acid with an alcohol having 1 to 6 carbon atoms.
TWO-STAGE PROCESS FOR PRODUCING TETRAALKYL 1,2,3,4 BUTANETETRACARBOXYLATES
A two-stage process produces tetraalkyl 1,2,3,4-butanetetracarboxylates having alkyl groups with 1 to 6 carbon atoms starting from tetrahydrophthalic anhydride (THPA). The process starts with an oxidation of tetrahydrophthalic anhydride (THPA), followed by a subsequent esterification of the resulting 1,2,3,4-butanetetracarboxylic acid with an alcohol having 1 to 6 carbon atoms.
NOVEL SALTS AND POLYMORPHIC FORM OF BEMPEDOIC ACID
The present invention relates to novel pharmaceutically acceptable salts of Bempedoic acid, novel intermediates of Bempedoic acid, novel crystalline form of Bempedoic acid and novel processes for the preparation of Bempedoic acid or its intermediates thereof.
NOVEL SALTS AND POLYMORPHIC FORM OF BEMPEDOIC ACID
The present invention relates to novel pharmaceutically acceptable salts of Bempedoic acid, novel intermediates of Bempedoic acid, novel crystalline form of Bempedoic acid and novel processes for the preparation of Bempedoic acid or its intermediates thereof.